QUIMOX

Specifications

Manufacturer

ALFA INTES INDUSTRIA TERAPEUTICA SPLENDORE S.R.L., Italy

Applicant company

TV TPI CO. LTD.

Active ingredient

Moxifloxacin

Content

25mg

Shelf life

24 months

Dosage Form

Ophthalmic solution

Package

Box of 1 vial x 5 ml

Visa Number

800115772524

Issuing Date

12/8/2024

Therapeutic area

Ophthalmologicals; anti-infectives, other anti-infectives

Indication

Quimox is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following microorganisms:
Aerobic Gram-positive microorganisms:
Corynebacterium species
Microbacterium species
Micrococcus luteus (including strains resistant to erythromycin, gentamycin, tetracycline and/or trimethoprim).
Staphylococcus aureus (including strains resistant to methicillin, erythromycin, gentamycin, ofloxacin, tetracycline and/or trimethoprim).
Staphylococcus epidermidis (including strains resistant to methicillin, erythromycin, gentamycin, ofloxacin, tetracycline and/or trimethoprim).
Staphylococcus haemolyticus (including strains resistant to methicillin, erythromycin, gentamycin, ofloxacin, tetracycline and/or trimethoprim).
Staphylococcus hominis (including strains resistant to methicillin, erythromycin, gentamycin, ofloxacin, tetracycline, and/or trimethoprim).
Staphylococcus warneri (including strains resistant to erythromycin).
Streptococcus pneumoniae (including strains resistant to penicillin, erythromycin, tetracycline, and/or trimethoprim).
Stretococcus viridans (including strains resistant to penicillin, erythromycin, tetracycline, and/or trimethoprim).
Aerobic Gram-negative microorganisms:
Acinetobacter species
Haemophilus alconae (including ampicillin-resistant strains).
Haemophilus influenzae (including ampicillin-resistant strains).
Haemophilus parainfluenzae
Klensialla pneumoniae
Moraxella cattarrhalis
Pseudomonas aeruginosa.
Other microorganisms:
Chlammydia trachomatis
Effectiveness on this microorganism has been studied in less than 10 infections.
In addition, Quimox eye drops are used in the following cases:
- Treatment of corneal ulcers.
- Use before and after surgery to prevent infection.

Dosage

Adults and elderly (≥ 65 years)
Insert 1 drop into the affected eye 3 times/day for 7 days. The inflammation usually improves after 5 days, treatment should be continued for 2-3 more days. If the inflammation does not improve after 5 days of treatment, the diagnosis and/or treatment should be reconsidered.
Children
No dosage adjustment is required.
People with liver and kidney failure
No dosage adjustment is required.